N/A N=18 Yoga as Self-Care for Arthritis in Minority Communities
Rheumatoid Arthritis · Arthritis
Primary: Self-Efficacy Exercise — 6.1 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=124 Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
Primary: Estimation of the Direct and Indirect Cost Incurred by Adalimumab Treatment — 272.99; 1162.62; 2662.73; 659.13 Euros
N/A N=360 Staying Positive With Arthritis Study
Arthritis
Primary: Self-reported Pain From Baseline to 1, 3, and 6 Months Post-intervention — 50.24; 47.42; 45.42; 43.57 units on a scale — p=0.791
N/A N=145 The Effect of n-3 Polyunsaturated Fatty Acids in Patients With Psoriatic Arthritis
Psoriatic Arthritis
Primary: Change in Heart Rate Variability (HRV) Measure — 13.38; -13.48 ms
N/A N=161 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs
Rheumatoid Arthritis · Ankylosing Spondylitis · Psoriatic Arthritis
Primary: RA and if Reasonable for PsA Patients Health Assessment Questionnaire Disability Index HAQ-DI — 1.2; 0.9; 1.1; 0.9 Units on a scale
N/A N=178 Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
Rheumatoid Arthritis · Psoriatic Arthritis · Periodontal Disease
Primary: Alteration of Microbiota, Alteration of T Cell Function/Activation — 4; 10; 2; 0 participants
Phase 3 N=86 Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)
Juvenile Psoriatic Arthritis · Enthesitis-related Arthritis
Primary: Number of Participants Experiencing a Flare During Treatment Period 2 — 10; 21 Participants — p=<0.001
N/A N=503 AsseSSing Impact in pSoriatic Treatment
Psoriatic Arthritis
Primary: Number of Patients Undergoing Treatment Escalation — 160 Participants
Phase 3 N=55 An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
Juvenile Psoriatic Arthritis · Enthesitis Related Arthritis
Primary: Percentage of Participants With Juvenile Idiopathic Arthritis American College of Rheumatology (JIA ACR) 30 Response — 100; 100; 100; 100 Percentage of Participants
Phase 3 N=127 Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
Juvenile Idiopahtic Arthritis
Primary: Number of Participants With Malignancy: All Periods of Parent and Extension Study — 1 Participants
N/A N=41 Hip Osteoarthritis: Effects of Exercise Programs on Pain and Disability
Hip Osteoarthritis
Primary: Change in 6-minute Walk Test — 22; 49 meters
Phase 3 N=1,675 Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients
Rheumatoid Arthritis
Primary: Part A: Percentage of Participants Achieving American College of Rheumatology 20% (ACR20) Response at Week 12 — 62; 72; 49; 66.7 Percentage of participants — p=0.1155
Phase 3 N=77 Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept
Rheumatoid Arthritis · Psoriatic Arthritis
Primary: Percentage of Successful Self-injections to Total Non-missed Injections — 97.8 percentage of successful injections
Phase 4 N=379 Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.
Rheumatoid Arthritis
Primary: Remission According to DAS28-CRP at Week 16 — 69; 72; 61; 25 Participants
N/A N=5,920 A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )
Rheumatoid Arthritis · Psoriatic Arthritis · Ankylosing Spondylitis
Primary: Change From Baseline in Physician's Assessment of Disease Activity Over Time — -34.4; -36.2; -40.2; -38.6 units on a scale